数据链接：
官方服务：
资源简介：
Inclusion and exclusion criteria of clinical study.
应用场景：
创建时间：
2023-04-06
相关数据集
sj-sas-7-smm-10.1177_09622802211051089 - Supplemental material for Allowing for stratification in sample size planning of two-arm trials with continuous or binary outcome: Overview and tutorial
Supplemental material, sj-sas-7-smm-10.1177_09622802211051089 for Allowing for stratification in sample size planning of two-arm trials with continuous or binary outcome: Overview and tutorial by Stef
DataCite Commons2024-08-28 更新80
Treatment Selection at Interim Analysis Based on a Correlated Early Endpoint in Adaptive Two-Stage Trials with a Primary Endpoint Based on Count Data
Adaptive two-stage design with treatment selection, also called seamless Phase II/III design, has been recognized to save sample size and time to enhance the development of effective treatments. These
Taylor & Francis Group2025-07-29 更新40
TS-1+ Oxaliplatin+ Bevacizumab therapy in consideration of OPTIMOX design for metastatic colorectal cancer
Interventions: TS-1+ Oxaliplatin+ Bevacizumab/TS-1+ Bevacizumab Primary outcome(s): DDC ; Duration of disease control Study Design: Single arm Non-randomized
NIAID Data Ecosystem30
Design and Analysis of Randomized Trials to Estimate Spatio-Temporally Heterogeneous Treatment Effects
In this article, we consider randomized trial design to evaluate interventions with spatially or spatio-temporally heterogeneous effects. A common approach in this setting is the cluster randomized tr
DataCite Commons2025-09-05 更新70
Additional file 4 of Sample size recalculation based on the overall success rate in a randomized test-treatment trial with restricting randomization to discordant pairs
Supplementary Material 4. Listing: Empirical Power
Figshare2025-03-18 更新40
